Farther Finance Advisors’s Mural Oncology MURA Stock Holding History

Farther Finance Advisors’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1	Closed	-$2	–	5547
2025 Q3	$2	Hold	1	–	–	﹤0.01%	4950
2025 Q2	$2	Hold	1	–	–	﹤0.01%	4480
2025 Q1	$1	Hold	1	–	–	﹤0.01%	4257
2024 Q4	$3	Hold	1	–	–	﹤0.01%	3983
2024 Q3	$3	Hold	1	–	–	﹤0.01%	3972
2024 Q2	$3	Hold	1	–	–	﹤0.01%	3804
2024 Q1	$5	Sell	1 -1	-50%	-$5	﹤0.01%	3578
2023 Q4	$12	Buy	+2	New	+$8	﹤0.01%	3488

Farther Finance Advisors's MURA Position: Q4 2025 in Review

Farther Finance Advisors sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 1 share — an estimated $2 sold.

Farther Finance Advisors first reported a position in MURA in Q4 2023 and held it in 8 quarters. The position peaked at $12 in Q4 2023. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

Farther Finance Advisors reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
Farther Finance Advisors sold 1 Mural Oncology share in Q4 2025, an estimated $2.
Farther Finance Advisors first reported a position in Mural Oncology in Q4 2023 and held it in 8 quarters.
Farther Finance Advisors's Mural Oncology position peaked at $12 in Q4 2023.
0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on Farther Finance Advisors's 13F filing for Q4 2025, filed 23 Jan 2026.